Thalidomide increases both intra-tumoural tumour necrosis factor-α production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid
Open Access
- 23 April 1999
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 80 (5), 716-723
- https://doi.org/10.1038/sj.bjc.6690415
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Inducer-Specific Bidirectional Regulation by Thalidomide and Phenylphthalimides of Tumor Necrosis Factor-α ProductionBiochemical and Biophysical Research Communications, 1996
- Treatment of cutaneous and pulmonary sarcoidosis with thalidomideJournal of the American Academy of Dermatology, 1995
- Thalidomide as replacement for steroids in immunosuppression after lung transplantationThe Annals of Thoracic Surgery, 1995
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Thalidomide Does not Perturb Cd2, Cd4, Cd5, Cd8, Hla-Dr, or HLA-A, B, C Molecules in Vitro on the Membranes of Cells with Immune PotentialImmunopharmacology and Immunotoxicology, 1994
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Induction of natural killer activity by Xanthenone analogues of flavone acetic acid: Relation with antitumour activityEuropean Journal of Cancer and Clinical Oncology, 1991
- Role of T cells and tumour necrosis factor in antitumour activity and toxicity of flavone acetic acidEuropean Journal of Cancer and Clinical Oncology, 1990
- Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.The Journal of Experimental Medicine, 1990
- THALIDOMIDE FOR GRAFT-VERSUS-HOST DISEASEThe Lancet, 1988